United States

Sumitomo Chemical Co Ltd (4005.T)

4005.T on Tokyo Stock Exchange

2:00am EDT
Change (% chg)

¥-9 (-1.35%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Sumitomo Dainippon Pharma U.S.-based unit enters agreement to divest asthma and allergy products to Covis pharma
Thursday, 13 Jul 2017 09:49pm EDT 

July 14 (Reuters) - Sumitomo Dainippon Pharma Co Ltd <4506.T>:* Says its U.S.-based unit Sunovion Pharmaceuticals Inc. has.* The transaction is expected to close during the first half of Fiscal Year 2017, subject to customary closing conditions.  Full Article

Sumitomo Dainippon Pharma unit receives Complete Response Letter from FDA for SUN-101/eFlow® New Drug Application for chronic obstructive pulmonary disease
Sunday, 28 May 2017 10:49pm EDT 

May 29(Reuters) - Sumitomo Dainippon Pharma Co Ltd <4506.T>:Says its US-based unit Sunovion Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for SUN-101/eFlow®(glycopyrrolate) for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD),including chronic bronchitis and/or emphysema, on May 26 (US Eastern time).Says the CRL does not require unit to conduct any additional clinical studies for the approval of SUN-101/eFlow®.  Full Article

Excel Crop Care becomes unit of Japan's Sumitomo Chemical Co Ltd
Friday, 7 Oct 2016 08:31am EDT 

Excel Crop Care: Sumitomo Chemical Co Ltd, Japan now promotoers of co holding 44.98 percent of co's paid up share capital . Shroff Family cease to be promoter of the co with immediate effect . Dipesh Shroff resigned as managing director; Chetan Shah appointed as MD with immediate effect .Co becomes unit of Sumitomo Chemical Co Ltd, Japan.  Full Article

Tanaka Chemical plans private placement to Sumitomo Chemical Co Ltd; shareholding structure changes
Wednesday, 31 Aug 2016 02:42am EDT 

Tanaka Chemical Corp <4080.T> : Says it plans to issue 10.5 million new shares via private placement to Sumitomo Chemical Co Ltd <4005.T>, to raise 6.57 billion yuan in total on Oct. 31 .Says Sumitomo Chemical Co Ltd, co's current top shareholder to raise stake in co to 50.10 percent up from 14.82 percent, and will still be the top shareholder after private placement.  Full Article

Monsanto and Sumitomo Chemical enter global crop protection collaboration for next generation PPO technologies
Monday, 27 Jun 2016 04:30pm EDT 

Monsanto Co : Monsanto and Sumitomo Chemical enter new global crop protection collaboration for next generation PPO technologies . Under agreement, Monsanto and Sumitomo Chemical will work together and in parallel to create integrated system of germplasm, biotechnology and crop protection . New generation PPO herbicide is expected to be available within brands offered by both companies . Next-generation herbicide is expected to be commercially available early in next decade, pending regulatory approvals .Additional details of agreement were not disclosed.  Full Article

Sumitomo Chemical amends consolidated mid-year outlook for FY 2016
Wednesday, 21 Oct 2015 04:00am EDT 

Sumitomo Chemical Co Ltd:Says the company lowered the consolidated mid-year outlook for revenue to 1,075,000 mln yen from 1,100,000 mln yen for the fiscal year ending March 2016.Operating profit forecast increased to 74,000 mln yen from 62,000 mln yen.Ordinary profit forecast increased to 100,000 mln yen from 70,000 mln yen.Net profit forecast increased to 60,000 mln yen from 38,000 mln yen.Earnings per share increased to 36.71 yen from 23.25 yen.Says revenue outlook lowered due to the decreased sale in core businesses, profit outlook raised due to yen devaluation.  Full Article

R&I affirms Sumitomo Chemical Co Ltd's rating at "A-" and announces stable outlook
Thursday, 8 Oct 2015 02:00am EDT 

Sumitomo Chemical Co Ltd:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-".Rating outlook stable.  Full Article

BRIEF- Sumitomo Chemical unit Sumitomo Dainippon Pharma announces unblinding of phase 3 study of Napabucasin

* Says its unit Sumitomo Dainippon Pharma Co Ltd announced today that the company decided to unblind the BRIGHTER study, a phase 3 global study in patients with gastric and gastro-esophageal junction (GEJ) cancer of napabucasin, an investigational cancer stemness inhibitor, based on a recommendation by the study’s independent Data and Safety Monitoring Board (DSMB), following a pre- specified interim analysis